BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 10:18 am
Please find enclosed intimation for closure of Trading Window w.e.f October 1, 2026.
GPT Healthcare Ltd · 544131
✦ AI Summary
GPT Healthcare Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the 2nd quarter and half year ending on September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GPT Healthcare Ltd - 544131 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
409debc1-2eca-4a84-916a-70e3ee44551d.pdf
View document text
GPT Healthcare Limited
Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402
Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in
GPTHEALTH/CS/SE/2026-27 September 28, 2026
The Department of Corporate Services National Stock Exchange of India Limited
BSE Limited, Exchange Plaza, Plot no. C/1, G Block,
Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E),
Dalal Street Mumbai - 400 051
Mumbai – 400001 Scrip Symbol: GPTHEALTH
Scrip Code: 544131
ISIN: INE486R01017
Dear Sir/Madam
Sub: Intimation of Closure of Trading Window.
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) and the
Company’s Code of Conduct to regulate, monitor and report trading by designated persons, the
trading window for dealing in the securities of the Company by the Designated Persons and
their immediate relatives shall remain closed from Thursday, October 01, 2026 till 48 (forty-
eight) hours after the declaration of the Un-Audited Financial Results of the Company for the
2nd quarter and half year ending on September 30, 2026.
The date of the Board meeting of the Company for consideration and approval of the Un-Audited
Financial Results for the 2nd quarter and half year ending on September 30, 2026 will be
intimated in due course.
Accordingly, all the Designated Persons of the Company and their immediate relatives are
advised not to trade in the securities of the Company during the aforesaid trading window
closure period.
The aforesaid information is also available on the website of the Company
https://ilshospitals.com
Kindly take the aforesaid information on record and oblige.
Thanking You,
Yours sincerely,
For GPT Healthcare Limited
Ankur Sharma
Company Secretary and Compliance Officer
M. No A31833